Clinical trial

Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-HE3-G3

NCT04277338

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-02-10

PhasePHASE1

Study timeline

Study start (actual)2020-02-10Date precision: day

Registry last updated2026-06-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Primary Breast Cancerunresolved

Interventions

SPECTDRUG

Sponsors & collaborators

Tomsk National Research Medical Center of the Russian Academy of Scienceslead sponsor

Institute of Bioorganic Chemistry, Russian Academy of Sciencescollaborator

Uppsala Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04277338 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.